MUST READ! China’s Secret To Controlling The Covid-19 Outbreak Is Traditional Chinese Medicine Concoctions Used Alone Or In Conjunction With Antiviral Protocols
Coronavirus Drug Research
: As early as 26th
Of January, in the early days of the Covid-19 epidemic, Thailand Medical News had published an article calling for more research into the use of Licorice Root (Glycyrrhiza glabra
) as a potential drug candidate for the SARS-Cov-2 coronavirus as many past research studies had shown its efficacy against the SARS virus of 2003.( https://www.thailandmedical.news/news/further-research-into-the-phytochemicals-contained-in-licorice-root-might-yield-a-treatment-for-the-new-coronavirus-strain-in-china
Unfortunately as we do not have the support of any Thai government agencies nor the support of the Thai companies and also the fact that we could not get our word out due to American social media platforms like Linkedin, Facebook and Twitter whose offices in Thailand, Singapore and India lowering your feeds as you are not advertising with them, we could not get our word out to help save more lives.
Licorice root has been used in Traditional Chinese Medicine and also in Indian Ayurvedic medicine for eons especially for respiratory ailments and diseases including pneumonia.
On the 3nd
Of February, the Chinese government started getting their TCM teams mobilized to test out various TCM concoctions and ingredients and in most cases, all contained licorice root.
It was demonstrated in various studies in China that for patients in the early stages of infections conditions, usage of TCM alone was sufficient to reduce the fevers, symptoms and viral loads to be deemed as ‘recovered’ while in the cases of patients in sever conditions, the usage of TCM in conjunction with various antiviral protocols, helped the patients to recover.
In a new peer reviewed study published in the Lancet (https://www.sciencedirect.com/science/article/pii/S1043661820307556?via%3Dihub
) it was shown that out of 102 confirmed infected patients in one study at Hubei exhibiting mild symptoms of the Covid-19 disease, almost all recovered just on TCM concoctions alone with symptoms and fevers disappearing even shorter compared to using antivirals and CT scans showed drastic improvements to the lungs coupled with NATS (nucleic acid tests) that showed negative presence of the SARS-CoV-2 coronavirus (note that residual dormant amounts of the virus will exist in all recovered as the NATS cannot pick up viral loads less than 90 copies per ml properly )
In addition, in the cases of patients with severe conditions, the administering of these concoctions along with various antiviral protocols helped to accelerate the process of recovery.
From the 16th of February onward, almost 87% of all treatments nationwide in China included TCM as part of the treatment protocols.
Based on traditional TCM protocols, 4 major concoctions showed efficacy including the Qingfei Paidu decoction(QPD), Gancaoganjiang decoction, Sheganmahuang decoction and the Qingfei Touxie Fuzheng decoction. (Any TCM shops in Thailand, Taiwan, Hong Kong, Singapore and Malaysia will know how to prepare this mixture of herbs).
In all the concoctions, Licorice root was the main ingredient used in a larger proportion.
The Qingfei Paidu decoction(QPD) was most favoured as it demonstrated the highest efficacy and been rebranded as different names including ‘Formula One’ In Guandong, The ‘TCM Antiviral’ In Shanghai, etc with state pharmaceutical and TCM companies mass producing it for sale in China but it has been restricted for export.
The exact ingredients for the Qingfei Paidu decoction(QPD) concoction is listed as Ephedrae Herba, Glycyrrhizae Radix et Rhizoma Praeprata cum Melle, Armeniacae Semen Amarum, Gypsum Fibrosum, Cinnamomi Ramulus, Alismatis Rhizoma, Polyporus, Atractylodis Macrocephalae Rhizoma, Poria, Bupleuri Radix, Scutellariae Radix, Pinelliae Rhizoma Praepratum cum Zingibere et Alumine, Zingiberis Rhizoma Recens, Asteris Radix et Rhizoma, Farfarae Flos, Belamcandae Rhizoma, Asari Radix et Rhizoma, Dioscoreae Rhizoma, Aurantii Fructus Immaturus, Citri Reticulatae Pericarpium, and Pogostemonis Herba.
However we at Thailand Medical News
notes that another important ingredient had been deliberately omitted from the list of which that particular herb is also being currently patented at the moment by the Chinese government.
This TCM preparation has been adopted since as a general prescription in the diagnosis and treatment plan of COVID-19 in China.
In another study of 701 confirmed cases treated by QPD, 130 cases were cured and discharged, clinical symptoms of 51 cases disappeared, 268 cases of symptoms improved, and 212 cases of stable symptoms without aggravation. The effective cure rate of QPD against COVID-19 is over 90 %.
We hope that more countries will take note of this study and do more research to help their own citizens.
For more on the coronavirus drug research
, keep logging to Thailand Medical News
N. Zhu, D. Zhang, W. Wang, X. Li, B. Yang, J. Song, X. Zhao, B. Huang, W. Shi, R. Lu, P. Niu, F. Zhan, X. Ma, D. Wang, W. Xu, G. Wu, G.F. Gao, W. TanChina novel coronavirus investigating and research team. A novel coronavirus from patients with pneumonia in China, 2019
N. Engl. J. Med., 382 (8) (2020), pp. 727-733
View Record in ScopusGoogle Scholar
National Health Commission of the People’s Republic of China. <Guideline on diagnosis and treatment of COVID-19 (Trial 6th edition). http://www.nhc.gov.cn/xcs/zhengcwj/202002/8334a8326dd94d329df351d7da8aefc2.shtml
(accessed Feb 23, 2020; in Chinese).
Publicity Department of the People’s Republic of China. Press conference of the joint prevention and control mechanism of state council on Feb 17, 2020. http://www.nhc.gov.cn/xcs/fkdt/202002/f12a62d10c2a48c6895cedf2faea6e1f.shtml
(accessed Feb 23, 2020; in Chinese).
Z. Xu, L. Shi, Y.J. Wang, J.Y. Zhang, L. Huang, C. ZhangPathological findings of COVID-19 associated with acute respiratory distress syndrome
Lancet Respir. Med. (2020), 10.1016/S2213-2600(20)30076-X
J. Zhao, S.S. Tian, J. Yang, J.F. Liu, W.D. Zhang, Investigating the mechanism of Qing-Fei-Pai-Du-Tang for the treatment of Novel Coronavirus Pneumonia by network pharmacology, Chinese Traditional and Herbal Drugs, http://kns.cnki.net/kcms/detail/12.1108.R.20200216.2044.002.html
H. Wu, J.Q. Wang, Y.W. Yang, T.Y. Li, Y.J. Cao, Y.X. Qu, Y.J. Jin, C.N. Zhang, Y.K. Sun, Preliminary exploration of the mechanism of Qingfei Paidu decoction agains novel coronavirus pneumonia based on network pharmacology and molecular docking technology, Acta Pharmaceutica Sinica. DOI: 10.16438/j.0513-4870.2020-0136.
H.L. Zhang, Y.X. Zhu, One highly suspected case of novel coronavirus pneumonia treated by Integrated Traditional Chinese and Western medicine and nucleic acid analysis, Tianjin Journal of Traditional Chinese Medicine. http://kns.cnki.net/kcms/detail/12.1349.R.20200227.0909.004.html.
This article was inspired by a kind benefactor who helped us today. May that person and their loved ones be blessed by the universe for their selfish deeds to help the masses who are being affected by the Covid-19 disease. (That person has no vested interests in any TCM suppliers or manufacturers or shops)
Please also help share our site and articles online as being a poor entity that is not profit orientated, we do not have any support from any Thai Government or private Thai companies as most Thai companies and corporations do not think that health of medical issues are of importance as they are more busy with their own greed. We also do not also get any support from the local private hospitals and pharma companies and organizations, hence we do not have monies to pay American social media platforms like Facebook, LinkedIn and Twitter whose local offices and regional offices in Singapore, Thailand, and India will lower your feed exposure as you are not advertising with them. For example with LinkedIn, though we have like 12,000 followers on our personal acct, but less than 200 can actually see our daily news postings as LinkedIn lowers the feed. We have the same problem with Twitter as well . We are basically a Thai medical mediatech and general mediatech startup that has never received any support from any entities in Thailand due to the prevalence of nepotism, corruption and also ego and incompetence on the part of certain senior executives and also the fact that Thais do not know how to collaborate and work together!
We like to thank the 3.8 million odd regular readers who have been following us so far.